69 related articles for article (PubMed ID: 19622580)
21. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
22. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F
Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856
[TBL] [Abstract][Full Text] [Related]
23. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
24. cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy.
Borkamo ED; Schem BC; Fluge Ø; Bruland O; Dahl O; Mella O
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1562-9. PubMed ID: 19931738
[TBL] [Abstract][Full Text] [Related]
25. Reduced mRNA and protein expression of the genomic caretaker RAD9A in primary fibroblasts of individuals with childhood and independent second cancer.
Weis E; Schoen H; Victor A; Spix C; Ludwig M; Schneider-Raetzke B; Kohlschmidt N; Bartsch O; Gerhold-Ay A; Boehm N; Grus F; Haaf T; Galetzka D
PLoS One; 2011; 6(10):e25750. PubMed ID: 21991345
[TBL] [Abstract][Full Text] [Related]
26. [Immunohistochemistry expression of 3 markers (CEA, UEA-I and Ki-67) in nasal inverted papillomas].
De Gabory L; Deminière C; Stoll D
Rev Laryngol Otol Rhinol (Bord); 2008; 129(3):159-65. PubMed ID: 19694158
[TBL] [Abstract][Full Text] [Related]
27. Incidental PET/CT findings in the cancer patient: how should they be managed?
Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
[TBL] [Abstract][Full Text] [Related]
28. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
Donson AM; Birks DK; Barton VN; Wei Q; Kleinschmidt-Demasters BK; Handler MH; Waziri AE; Wang M; Foreman NK
J Immunol; 2009 Dec; 183(11):7428-40. PubMed ID: 19917695
[TBL] [Abstract][Full Text] [Related]
29. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of DNA base-excision repair genes APE/Ref-1 and XRCC1 are not associated with the risk for Graves' disease.
Doğru-Abbasoğlu S; Tanrikulu S; Ademoğlu E; Erbil Y; Ozderya A; Karadağ B; Uysal M
Cell Biochem Funct; 2009 Oct; 27(7):462-7. PubMed ID: 19711438
[TBL] [Abstract][Full Text] [Related]
31. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression predicts metachronous pulmonary metastasis and poor survival in patients with hepatoblastoma.
Tsukada M; Wakai T; Matsuda Y; Korita PV; Shirai Y; Ajioka Y; Hatakeyama K; Kubota M
J Pediatr Surg; 2009 Aug; 44(8):1522-8. PubMed ID: 19635299
[TBL] [Abstract][Full Text] [Related]
32. Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases.
Powell S; Dudek AZ
Anticancer Res; 2009 Oct; 29(10):4189-93. PubMed ID: 19846971
[TBL] [Abstract][Full Text] [Related]
33. Ocular manifestation in treated multibacillary Hansen's disease.
Parikh R; Thomas S; Muliyil J; Parikh S; Thomas R
Ophthalmology; 2009 Nov; 116(11):2051-7.e1. PubMed ID: 19766316
[TBL] [Abstract][Full Text] [Related]
34. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
35. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma.
Advani R; Forero-Torres A; Furman RR; Rosenblatt JD; Younes A; Ren H; Harrop K; Whiting N; Drachman JG
J Clin Oncol; 2009 Sep; 27(26):4371-7. PubMed ID: 19636010
[TBL] [Abstract][Full Text] [Related]
37. Microarray evaluation of age-related changes in human dental pulp.
Tranasi M; Sberna MT; Zizzari V; D'Apolito G; Mastrangelo F; Salini L; Stuppia L; Tetè S
J Endod; 2009 Sep; 35(9):1211-7. PubMed ID: 19720218
[TBL] [Abstract][Full Text] [Related]
38. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
40. Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targets.
Adams H; Campidelli C; Dirnhofer S; Pileri SA; Tzankov A
Expert Opin Ther Targets; 2009 Oct; 13(10):1137-45. PubMed ID: 19705967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
